Doctor profile · Federal record
Dr. Panayotis Ledakis, MD
Hematology & Oncology Physician (CMS: Medical Oncology) · Baltimore, MD
- NPI 1649385634
- Accepts Medicare
- MIPS 83.3 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
227 St Paul Place, 4Th Floor
Baltimore, MD 212022001
(410) 783-5858
fax (410) 783-5864
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D047934
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649385634. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
263,307
Distinct HCPCS
10
Medicare allowed
$3,756,216
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1756 |
Injection, iron sucrose, 1 mg | 61,200 | 85 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 55,080 | 51 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 39,100 | 50 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 33,600 | 35 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 23,280 | 12 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 19,680 | 128 | $23 | |
J1453 |
Injection, fosaprepitant, 1 mg | 11,250 | 28 | $0 | |
J9171 |
Injection, docetaxel, 1 mg | 4,494 | 12 | $1 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,570 | 63 | $0 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 1,472 | 33 | $0 |
In context: peer comparison
Among 33 peers in this city , average services per provider: 1,998. This provider delivers 132× the peer median.Open Payments
Industry payments received
All-time total
$1,182
Transactions
31
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Intera Oncology, Inc | 2 | $322.04 | |
| ABBVIE INC. | 4 | $110.14 | |
| PFIZER INC. | 4 | $97.04 | |
| Novartis Pharmaceuticals Corporation | 3 | $77.60 | |
| Incyte Corporation | 1 | $68.69 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $64.88 | |
| Merck Sharp & Dohme LLC | 3 | $58.63 | |
| Daiichi Sankyo Inc. | 2 | $55.69 | |
| Tempus AI, Inc | 2 | $54.48 | |
| Astellas Pharma US Inc | 2 | $41.70 | |
| Alnylam Pharmaceuticals Inc. | 2 | $32.22 | |
| Pharmacosmos Therapeutics Inc. | 1 | $27.72 | |
| Mirati Therapeutics, Inc. | 1 | $25.76 | |
| GlaxoSmithKline, LLC. | 1 | $24.46 | |
| Cumberland Pharmaceuticals, Inc. | 1 | $23.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
357
Patients
108
Total drug cost
$111,500
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 72 | 23 | $55,968 |
| Xarelto (Rivaroxaban) | Brand | 50 | 14 | $51,644 |
| Letrozole | Generic | 37 | 0 | $918 |
| Prednisone | Generic | 29 | 13 | $150 |
| Anastrozole | Generic | 25 | 12 | $1,317 |
| Tramadol Hcl | Generic | 23 | 17 | $105 |
| Hydroxyurea | Generic | 20 | 0 | $303 |
| Oxycodone Hcl | Generic | 20 | 17 | $295 |
| Furosemide | Generic | 18 | 0 | $31 |
| Ibuprofen | Generic | 18 | 0 | $65 |
Hospital affiliations
Frequently asked questions
What is Dr. Panayotis Ledakis's medical specialty?
Dr. Panayotis Ledakis practices Hematology & Oncology Physician in Baltimore, MD.
Where does Dr. Panayotis Ledakis practice?
Dr. Panayotis Ledakis practices at 227 St Paul Place, Baltimore, MD 212022001. Office phone: 4107835858.
What is Dr. Panayotis Ledakis's NPI?
Dr. Panayotis Ledakis's National Provider Identifier (NPI) is 1649385634, issued by NPPES.
Does Dr. Panayotis Ledakis accept Medicare assignment?
Yes. Dr. Panayotis Ledakis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Panayotis Ledakis commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.